Translational Research Initiative for Hearing Grant


UK national charity sets up cross channel partnership with Fondation Pour l'Audition to help develop treatments for hearing loss and tinnitus.

Research (06/02/2019)


Fondation Pour l'Audition has partnered up with a renowned British Organisation Action on Hearing Loss to jointly fund research towards the development of new drug, gene and cell-based treatments for hearing disorders, including tinnitus.

According to the World Health Organisation there are almost half a billion people around the world with disabling hearing loss. Despite the scale of this global issue, treatments are currently limited to just hearing aids and cochlear implants.  To help tackle this the two organisations will invest up to £300,000 (Action on Hearing Loss) and up to €300,000 (Fondation Pour l’ Audition) over 3 years, to support crucial projects in both universities and biotech companies all over the world.

Action on Hearing Loss is the UK's leading charity helping people with deafness, tinnitus or hearing loss to live better lives. It funds scientific research to find solutions to hearing loss and encourages the adoption of new technologies. Although Action on Hearing Loss is based and operating in the UK, the partnership with the Fondation Pour l'Audition is a major step towards building links with other organizations around the world to find new ones. treatments for the hearing impaired.

Dr Ralph Holme, Executive Director of Research at Action on Hearing Loss said: “We are thrilled to be partnering up with such a reputable foundation who, like us, tirelessly campaign and fund crucial research for people living with hearing loss and tinnitus. It is of paramount importance that organisations around the world work together in a coordinated effort to support the development of treatments that have the potential to transform the lives of people.”

Karine Rossignol, General Director of Fondation Pour l’ Audition said: “We believe in team work and in that by working together we will accelerate the development of treatments. This partnership, which is a true message of hope for people with hearing loss and tinnitus, marks the beginning of a long collaboration between the two organisations”.